
|Articles|February 1, 1997
Supplements and Featured Publications
- Looking Beyond the Formulary Budget: Cost Analysis and a Psychiatric Perspective
- Volume 3
- Issue 2 Suppl
Evaluating the Cost Effectiveness of Newer Psychotropic Medications
Author(s)Gary L. Viale, PharmD
Advertisement
Articles in this issue
almost 29 years ago
Introduction: Looking Beyond the Formulary Budgetalmost 29 years ago
Looking Beyond the Formulary Budget in Cost-Benefit Analysisalmost 29 years ago
Retrospective Analysis of the Effect of Risperidone on Clinical Outcomealmost 29 years ago
Newer Antipsychotic Medications: Discussionsalmost 29 years ago
Bibliographyalmost 29 years ago
ParticipantsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
House Republicans Block Vote on ACA Subsidy Extension
2
Zasocitinib Hits Phase 3 End Points in Plaque Psoriasis
3
FDA Approval of Subcutaneous Amivantamab Offers Faster, Safer Option for EGFR-Mutated NSCLC
4
ICYMI: Highlights From the 2025 ASPC Congress on CVD Prevention
5









































